Form 4 for CALC CalciMedica, Inc.
Accepted 2026-06-29 08:45:05 ET · period of report 2026-06-25 · accession 0001484729-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-29 08:45 | 2026-06-25 | CALC | Leheny A. Rachel | CEO, Dir, 10% | A - Grant | $0.8033 | +186.7K | 317.7K | +143% | +$150.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-25 | A | A | 186,729 | $0.8033 | 317,655 | D | — | — | (F1) The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors. |